Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_assertion type Assertion NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_head.
- NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_assertion description "[The reduction of ADARB2 correlated with the grade of malignancy of glioblastoma multiforme, the most aggressive of brain tumors, displaying a 99% decrease in ADARB2 RNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_provenance.
- NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_assertion evidence source_evidence_literature NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_provenance.
- NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_assertion SIO_000772 17908822 NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_provenance.
- NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_assertion wasDerivedFrom befree-20150227 NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_provenance.
- NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_assertion wasGeneratedBy ECO_0000203 NP223109.RAV9x1OquGO0hXn-eNkC_wXeWBnWEOPVgKoNE0KYMtjEE130_provenance.